The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer

被引：43

作者：

Shibata, MA ^{[1
]}

Jorcyk, CL ^{[1
]}

Liu, ML ^{[1
]}

Yoshidome, K ^{[1
]}

Gold, LG ^{[1
]}

Green, JE ^{[1
]}

机构：

[1] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA

来源：

TOXICOLOGIC PATHOLOGY | 1998年 / 26卷 / 01期

关键词：

D O I：

10.1177/019262339802600121

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

[No abstract available]

引用

页码：177 / 182

页数：6

共 38 条

[1]

BARRIOS R, 1996, TRANSGENICS, V2, P23

[2]

BOSLAND MC, 1992, J CELL BIOCHEM, P89

[3]

BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO

[4]

2-I

[5]

BOSTWICK DG, 1995, CANCER-AM CANCER SOC, V75, P1823, DOI 10.1002/1097-0142(19950401)75:7+<1823::AID-CNCR2820751612>3.0.CO

[6]

2-7

[7] TRANSGENIC MICE HARBORING SV40 T-ANTIGEN GENES DEVELOP CHARACTERISTIC BRAIN-TUMORS [J].

BRINSTER, RL ;

CHEN, HY ;

MESSING, A ;

VANDYKE, T ;

LEVINE, AJ ;

PALMITER, RD .

CELL, 1984, 37 (02) :367-379

[8]

EMMERTBUCK MR, 1995, CANCER RES, V55, P2959

[9]

GREEN JE, 1998, IN PRESS PROSTATE, V33

[10]

GREENBERG NM, 1996, P NATL ACAD SCI USA, V39, pA59

← 1 2 3 4 →